Citation: M. Chetty et al., NO CORRELATION BETWEEN TEST DOSE OF CHLORPROMAZINE AND THERAPEUTIC RESPONSE IN RELAPSED SCHIZOPHRENIC-PATIENTS AFTER A WASH-OUT PERIOD OF 1-2 WEEKS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35167-35167
Citation: M. Chetty et al., RESPONSE IN CHRONIC-SCHIZOPHRENIA CORRELATED WITH CHLORPROMAZINE, 7-OH-CHLORPROMAZINE AND CHLORPROMAZINE SULFOXIDE LEVELS, European neuropsychopharmacology, 6(2), 1996, pp. 85-91
Citation: M. Chetty et al., IMPORTANT METABOLITES TO MEASURE IN PHARMACODYNAMIC STUDIES OF CHLORPROMAZINE, Therapeutic drug monitoring, 16(1), 1994, pp. 30-36
Citation: M. Chetty et al., SMOKING AND BODY-WEIGHT INFLUENCE THE CLEARANCE OF CHLORPROMAZINE, European Journal of Clinical Pharmacology, 46(6), 1994, pp. 523-526
Citation: Sv. Moodley et Al. Pillay, 2 YEARS OF ADMISSIONS TO NATAL FIRST INPATIENT CHILD MENTAL-HEALTH-CENTER, South African medical journal, 83(3), 1993, pp. 209-211